Cathy Malcontenti‐Wilson

Effect of ACE inhibitors and angiotensin II receptor antagonists in a mouse model of colorectal cancer liver metastases

Jaclyn Neo, Cathy Malcontenti‐Wilson, Vijayaragavan Muralidharan et al. · Journal of Gastroenterology and Hepatology · 2006 · 124 citations

Medicine, Oncology, Pharmacology +15

Effect of nonsteroidal anti-inflammatory drugs on LFA-1 and ICAM-1 expression in gastric mucosa

Fiona Andrews, Cathy Malcontenti‐Wilson, Paul E. O’Brien · American Journal of Physiology-Gastrointestinal and Liver Physiology · 1994 · 90 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Protection against gastric ischemia-reperfusion injury by nitric oxide generators

Fiona Andrews, Cathy Malcontenti‐Wilson, P. E. O'Brien · Digestive Diseases and Sciences · 1994 · 74 citations · Full text

Medicine, Surgery, Enhanced Recovery After Surgery +8

Non-steroidal anti-inflammatory drugs with activity against either cyclooxygenase 1 or cyclooxygenase 2 inhibit colorectal cancer in a DMH rodent model by inducing apoptosis and inhibiting cell proliferation

Wendy A. Brown, Stewart Skinner, Cathy Malcontenti‐Wilson et al. · Gut · 2001 · 59 citations · Full text

Medicine, Oncology, Pharmacology +15

<i>In vitro</i> and <i>in vivo</i> evaluation of tumor targeting styrene‐maleic acid copolymer‐pirarubicin micelles: Survival improvement and inhibition of liver metastases

Jurstine Daruwalla, Mehrdad Nikfarjam, Khaled Greish et al. · Cancer Science · 2010 · 54 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17